109 related articles for article (PubMed ID: 18769754)
1. [Serum free light chains: clinical utility].
Encinas Madrazo A; González García ME; Cepeda Piorno J; González Huerta AJ; Fernández Rodríguez E
An Med Interna; 2008 May; 25(5):249-50. PubMed ID: 18769754
[No Abstract] [Full Text] [Related]
2. Novel extended reference range for serum kappa/lambda free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
Diamantidis MD; Ioannidou-Papagiannaki E; Ntaios G
Clin Biochem; 2009 Jul; 42(10-11):1202-3. PubMed ID: 19375413
[No Abstract] [Full Text] [Related]
3. A case of IgM paraproteinemia in which serum free light chain values were within reference intervals.
Ma ES; Lee ET
Clin Chem; 2007 Feb; 53(2):362-3. PubMed ID: 17259251
[No Abstract] [Full Text] [Related]
4. Improved monitoring of differences in serial laboratory results.
Fraser CG
Clin Chem; 2011 Dec; 57(12):1635-7. PubMed ID: 21976551
[No Abstract] [Full Text] [Related]
5. Verification of serum reference intervals for free light chains in a local South African population.
Zemlin AE; Rensburg MA; Ipp H; Germishuys JJ; Erasmus RT
J Clin Pathol; 2013 Nov; 66(11):992-5. PubMed ID: 23801498
[TBL] [Abstract][Full Text] [Related]
6. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance.
Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA
Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291
[TBL] [Abstract][Full Text] [Related]
7. A case of light chain deposition disease involving the kidney with a normal serum free kappa/lambda light chain ratio.
Zhang S; Ni H; Xu Q; Cai X; Li H; Wei Z; Cao J
Ren Fail; 2022 Dec; 44(1):103-105. PubMed ID: 35156899
[No Abstract] [Full Text] [Related]
8. Comparison of free κ and λ light chain immunoassays and total (bound and free) κ and λ light chain immunoassays.
Delgado F; Kuus K
Rev Invest Clin; 2014; 66(5):473-4. PubMed ID: 25695391
[No Abstract] [Full Text] [Related]
9. Amyloidosis: clinical pentad.
Mookadam F; Mookadam M; Jiamsripong P
Intern Med J; 2011 Jan; 41(1a):66-7. PubMed ID: 21265964
[No Abstract] [Full Text] [Related]
10. Serum free light chain specificity and sensitivity: a reality check.
Katzmann JA
Clin Chem; 2006 Sep; 52(9):1638-9. PubMed ID: 16940461
[No Abstract] [Full Text] [Related]
11. Serum free light chain analysis.
Davids MS; Murali MR; Kuter DJ
Am J Hematol; 2010 Oct; 85(10):787-90. PubMed ID: 20721885
[TBL] [Abstract][Full Text] [Related]
12. Efficient use of basic biochemical methods to prove the presence of monoclonal protein in the clinical diagnosis of malignant monoclonal gammopathy.
Cermáková Z; Gottwaldová J; Dastych M; Adam Z; Zahradová L
Clin Chem Lab Med; 2013 Oct; 51(10):e243-5. PubMed ID: 23633467
[No Abstract] [Full Text] [Related]
13. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy.
Wolff F; Thiry C; Willems D
Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359
[TBL] [Abstract][Full Text] [Related]
15. Quantification of serum free light chain kappa and lambda by the SPAPLUS analyser.
Maisin D; Lepoutre T; Gruson D; Wallemacq P
Clin Biochem; 2013 May; 46(7-8):622-6. PubMed ID: 23291296
[TBL] [Abstract][Full Text] [Related]
16. Over- and underestimation of monoclonal gammopathies by quantification of kappa- and lambda-containing immunoglobulins in serum.
Bush D; Keren DF
Clin Chem; 1992 Feb; 38(2):315-6. PubMed ID: 1541022
[No Abstract] [Full Text] [Related]
17. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies: High False-Positive Rate.
Singh G
Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin free light chains in patients with monoclonal gammapathies.
Lubimova NV; Turko TA; Votyakova OM; Kushlinskii NE
Bull Exp Biol Med; 2012 Jun; 153(2):249-54. PubMed ID: 22816095
[TBL] [Abstract][Full Text] [Related]
19. A multicentre study comparing two methods for serum free light chain analysis.
Lock RJ; Saleem R; Roberts EG; Wallage MJ; Pesce TJ; Rowbottom A; Cooper SJ; McEvoy ED; Taylor JL; Basu S
Ann Clin Biochem; 2013 May; 50(Pt 3):255-61. PubMed ID: 23605135
[TBL] [Abstract][Full Text] [Related]
20. Serum-free light chain analysis: works in progress.
Merlini G
Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
